Comments

Vertex Pharmaceuticals Stock Guidance

VRTXNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$445.93
1.290.29%
At close: Dec 11, 4:00 PM EST
$446.33
0.400.09%
After Hours: 6:44 PM EST
OverviewNewsEarningsOptions

Guidance

Analyst RatingsInsider TradesShort InterestGovernment TradesStock Report

Vertex Pharmaceuticals Stock Guidance | NASDAQ:VRTX | Benzinga

Vertex Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
11/03/2025VRTX
Vertex Pharmaceuticals
FY2025———$11.90B$12.00B$11.99BGet Alert
08/04/2025VRTX
Vertex Pharmaceuticals
FY2025———$11.85B$12.00B$11.93BGet Alert
05/05/2025VRTX
Vertex Pharmaceuticals
FY2025———$11.85B$12.00B$11.98BGet Alert
02/10/2025VRTX
Vertex Pharmaceuticals
FY2025———$11.75B$12.00B$11.85BGet Alert
11/04/2024VRTX
Vertex Pharmaceuticals
FY2024———$10.80B$10.90B$10.75BGet Alert
08/01/2024VRTX
Vertex Pharmaceuticals
FY2024———$10.65B$10.85B$10.76BGet Alert
05/06/2024VRTX
Vertex Pharmaceuticals
FY2024———$10.55B$10.75B$10.70BGet Alert
02/05/2024VRTX
Vertex Pharmaceuticals
FY2024———$10.55B$10.75B$10.61BGet Alert
11/06/2023VRTX
Vertex Pharmaceuticals
FY2023———$9.85B$9.85B$9.87BGet Alert
08/01/2023VRTX
Vertex Pharmaceuticals
FY2023———$9.70B$9.80B$9.75BGet Alert
05/01/2023VRTX
Vertex Pharmaceuticals
FY2023———$9.55B$9.70B$9.71BGet Alert
02/07/2023VRTX
Vertex Pharmaceuticals
FY2023———$9.55B$9.70B$9.60BGet Alert
10/27/2022VRTX
Vertex Pharmaceuticals
FY2022———$8.80B$8.90B$8.77BGet Alert
08/04/2022VRTX
Vertex Pharmaceuticals
FY2022———$8.60B$8.80B$8.58BGet Alert
05/05/2022VRTX
Vertex Pharmaceuticals
FY2022———$8.40B$8.60B$8.58BGet Alert
01/26/2022VRTX
Vertex Pharmaceuticals
FY2022———$8.40B$8.60B$8.22BGet Alert

FAQ

Q

What is the most recent guidance for Vertex Pharmaceuticals (VRTX)?

A

There have been no specific sales or earnings guidance reported for Vertex Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

BeOne Medicines Ltd
NASDAQ:ONC
$320.84
%
Exact Sciences Corp
NASDAQ:EXAS
$101.36
%
Neurocrine Biosciences Inc
NASDAQ:NBIX
$154.75
%
Ionis Pharmaceuticals Inc
NASDAQ:IONS
$79.14
%
Roivant Sciences Ltd
NASDAQ:ROIV
$21.50
0.75%
Amgen Inc
NASDAQ:AMGN
$319.45
0.65%
United Therapeutics Corp
NASDAQ:UTHR
$488.51
%
BioNTech SE
NASDAQ:BNTX
$96.22
0.23%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved